NCT02608788

Brief Summary

The purpose of intubation for patients under general anesthesia is to maintain their respiratory function. However, this procedure does cause a postoperative sore throat. Comfort of patients could be promoted if effective treatment could be found. The specific aims of this project are:

  1. 1.Comparing the Efficacies Between the Spray of S.L. Spray Solution and Difflam to Release Postoperative Sore Throat.
  2. 2.Acular spray for the prevention of postoperative sore throat.
  3. 3.Comparing the Efficacies Between the Spray of S.L. Spray Solution and Difflam and Acular to Release Postoperative Sore Throat.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
380

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Sep 2014

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 16, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
Last Updated

May 21, 2021

Status Verified

October 1, 2015

Enrollment Period

10 months

First QC Date

October 16, 2015

Last Update Submit

May 20, 2021

Conditions

Keywords

postoperative sore throatAmerican Society of Anesthesiologists statusgeneral anesthesiapost-anesthesia care unit(PACU)

Outcome Measures

Primary Outcomes (1)

  • pain scale (Numeric Rating Scale: 0-10)

    1.5 year

Secondary Outcomes (1)

  • nonsteroidal antiinflammatory drug side effect

    1.5 year

Study Arms (4)

S.L.® & Difflam Forte ®

ACTIVE COMPARATOR

"1.5 mg/ml Benzydamine" , "S.L.® Spray Solution" 2.5 mg and "3.0 mg/ml Benzydamine" ,Difflam Forte ® 5.0 mg spray by mouth. Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Drug: S.L.®

placebo ( for Acular® )

PLACEBO COMPARATOR

placebo(distilled water)spray by mouth. Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Drug: placebo

Acular® & S.L.®

ACTIVE COMPARATOR

"5% Ketorolac Tromethamine" , "Acular®" 8.0 mg and "1.5 mg/ml Benzydamine" , "S.L.® Spray Solution" 2.5 mg spray by mouth. Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Drug: Acular®

Difflam Forte ® & Acular®

EXPERIMENTAL

"3.0 mg/ml Benzydamine" , "Difflam Forte ®" 5.0 mg and "5% Ketorolac Tromethamine" "Acular®" 8.0 mg spray by mouth. Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Drug: Difflam Forte ®

Interventions

S.L.®DRUG

"1.5mg/ml Benzydamine hydrochloride"," S.L.®" spray by mouth . Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Also known as: Andolex®
S.L.® & Difflam Forte ®

"3.0mg/ml Benzydamine hydrochloride" , " Difflam Forte ®" spray by mouth . Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Also known as: Tantum Verde®
Difflam Forte ® & Acular®

"5% Ketorolac Tromethamine" , " Acular® " spray by mouth . Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Also known as: Apo-Ketorolac® Ophthalmic
Acular® & S.L.®

Distilled water spray by mouth. Before intubation, each endotracheal tube cuff was scattered 10 times of spray by physicians that might cover 20 cm long of the cuff.

Also known as: distilled water
placebo ( for Acular® )

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • intubation for patients under general anesthesia
  • age\>20
  • none pre-operative sore throat
  • by the researchers explain research purposes, the researchers agreed to participate

You may not qualify if:

  • postoperative on N-G tube
  • Surgical side is located by the mouth or throat
  • thyroidectomy
  • difficult airway
  • none extubation at PACU
  • on patient-controlled analgesia
  • the medical records have a history of nonsteroidal antiinflammatory drugs allergy
  • medical records have kidney disease or a history of renal dysfunction
  • peptic ulcer
  • pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Hung NK, Wu CT, Chan SM, Lu CH, Huang YS, Yeh CC, Lee MS, Cherng CH. Effect on postoperative sore throat of spraying the endotracheal tube cuff with benzydamine hydrochloride, 10% lidocaine, and 2% lidocaine. Anesth Analg. 2010 Oct;111(4):882-6. doi: 10.1213/ANE.0b013e3181d4854e. Epub 2010 Mar 19.

    PMID: 20304980BACKGROUND

MeSH Terms

Conditions

Pharyngitis

Interventions

Ketorolac Tromethamine

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

IndomethacinIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Hsiu-Ling Yang, RN, MS

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2015

First Posted

November 20, 2015

Study Start

September 1, 2014

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

May 21, 2021

Record last verified: 2015-10

Data Sharing

IPD Sharing
Will not share